{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:04:48Z","timestamp":1791295488215,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1016\/j.redox.2013.06.004","type":"journal-article","created":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T23:18:49Z","timestamp":1374189529000},"page":"398-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids"],"prefix":"10.1016","volume":"1","author":[{"given":"M. Grazia","family":"Cotticelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Crabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail S.","family":"Shchepinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"R1","key":"10.1016\/j.redox.2013.06.004_bib1","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1093\/hmg\/ddq165","article-title":"Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches","volume":"19","author":"Schmucker","year":"2010","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"10.1016\/j.redox.2013.06.004_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/ars.2009.3015","article-title":"Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities","volume":"13","author":"Santos","year":"2010","journal-title":"Antioxidants and Redox Signaling"},{"issue":"35","key":"10.1016\/j.redox.2013.06.004_bib3","doi-asserted-by":"crossref","first-page":"26737","DOI":"10.1074\/jbc.R110.118679","article-title":"Frataxin and mitochondrial FeS cluster biogenesis","volume":"285","author":"Stemmler","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"1-2","key":"10.1016\/j.redox.2013.06.004_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.brainresrev.2011.04.001","article-title":"Friedreich's ataxia: past, present and future","volume":"67","author":"Marmolino","year":"2011","journal-title":"Brain Research Reviews"},{"issue":"1\u20132","key":"10.1016\/j.redox.2013.06.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich's ataxia: pathology, pathogenesis, and molecular genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.redox.2013.06.004_bib6","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/hmg\/11.17.2025","article-title":"The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe\/S proteins","volume":"11","author":"Muhlenhoff","year":"2002","journal-title":"Human Molecular Genetics"},{"issue":"18","key":"10.1016\/j.redox.2013.06.004_bib7","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1093\/emboj\/cdg446","article-title":"Components involved in assembly and dislocation of iron\u2013sulfur clusters on the scaffold protein Isu1p","volume":"22","author":"Muhlenhoff","year":"2003","journal-title":"EMBO Journal"},{"key":"10.1016\/j.redox.2013.06.004_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","article-title":"Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of Frataxin","volume":"276","author":"Babcock","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.redox.2013.06.004_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng0897-352","article-title":"Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue","volume":"16","author":"Wilson","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1016\/j.redox.2013.06.004_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0014-5793(97)00734-5","article-title":"Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria","volume":"411","author":"Foury","year":"1997","journal-title":"FEBS Letters"},{"key":"10.1016\/j.redox.2013.06.004_bib11","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1074\/jbc.274.8.4497","article-title":"The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondrial iron cycle","volume":"274","author":"Radisky","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.redox.2013.06.004_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0014-5793(99)00961-8","article-title":"Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain","volume":"456","author":"Foury","year":"1999","journal-title":"FEBS Letters"},{"key":"10.1016\/j.redox.2013.06.004_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron\u2013sulphur protein deficiency in Friedreich's ataxia","volume":"17","author":"Rotig","year":"1997","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.redox.2013.06.004_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical biochemical and molecular genetic correlations in Friedreich's ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.redox.2013.06.004_bib15","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","article-title":"Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia\u2018","volume":"96","author":"Lodi","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.redox.2013.06.004_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.1001","article-title":"Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia","volume":"49","author":"Lodi","year":"2001","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/j.redox.2013.06.004_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe\u2013S enzyme deficiency followed by intramitochondrial iron deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/j.redox.2013.06.004_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mus.10077","article-title":"Near-infrared muscle spectroscopy in patients with Friedreich's ataxia","volume":"25","author":"Lynch","year":"2002","journal-title":"Muscle and Nerve"},{"issue":"11","key":"10.1016\/j.redox.2013.06.004_bib19","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1212\/WNL.55.11.1719","article-title":"Oxidative stress in patients with Friedreich ataxia. [see comments]","volume":"55","author":"Schulz","year":"2000","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.redox.2013.06.004_bib20","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.55.11.1752","article-title":"Increased levels of plasma malondialdehyde in Friedreich ataxia. [see comments]","volume":"55","author":"Emond","year":"2000","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.redox.2013.06.004_bib21","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/ddn127","article-title":"Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia","volume":"17","author":"Li","year":"2008","journal-title":"Human Molecular Genetics"},{"issue":"13","key":"10.1016\/j.redox.2013.06.004_bib22","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1182\/blood-2008-06-161919","article-title":"Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation","volume":"112","author":"Kakhlon","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.redox.2013.06.004_bib23","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1096\/fj.09-143222","article-title":"Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question","volume":"24","author":"Armstrong","year":"2010","journal-title":"FASEB Journal"},{"issue":"1","key":"10.1016\/j.redox.2013.06.004_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/10408448709089856","article-title":"Lipid peroxidation and mechanisms of toxicity","volume":"18","author":"Horton","year":"1987","journal-title":"Critical Reviews in Toxicology"},{"issue":"3","key":"10.1016\/j.redox.2013.06.004_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0006-291X(83)91366-9","article-title":"The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron","volume":"111","author":"Bucher","year":"1983","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"22","key":"10.1016\/j.redox.2013.06.004_bib26","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1016\/S0021-9258(18)67521-0","article-title":"The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation","volume":"261","author":"Braughler","year":"1986","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.redox.2013.06.004_bib27","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","article-title":"Lipid peroxidation and neurodegenerative disease","volume":"51","author":"Reed","year":"2011","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1016\/j.redox.2013.06.004_bib28","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1021\/ja00067a019","article-title":"Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein","volume":"115","author":"Bowry","year":"1993","journal-title":"Journal of the American Chemical Society"},{"issue":"9177","key":"10.1016\/j.redox.2013.06.004_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(99)01341-0","article-title":"Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study","volume":"354","author":"Rustin","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2013.06.004_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/heart.87.4.346","article-title":"Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. [see comments.]","volume":"87","author":"Hausse","year":"2002","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.redox.2013.06.004_bib31","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1212\/01.WNL.0000055872.50364.FC","article-title":"Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial","volume":"60","author":"Mariotti","year":"2003","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.redox.2013.06.004_bib32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1212\/01.WNL.0000068549.52812.0F","article-title":"Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring","volume":"60","author":"Buyse","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.redox.2013.06.004_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/j.redox.2013.06.004_bib34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.64.6.803","article-title":"Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia","volume":"64","author":"Di Prospero","year":"2007","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/j.redox.2013.06.004_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.arr.2008.04.001","article-title":"Detoxification reactions: relevance to aging","volume":"7","author":"Zimniak","year":"2008","journal-title":"Ageing Research Reviews"},{"issue":"5","key":"10.1016\/j.redox.2013.06.004_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.freeradbiomed.2009.05.032","article-title":"Lipid peroxidation: physiological levels and dual biological effects","volume":"47","author":"Niki","year":"2009","journal-title":"Free Radical Biology and Medicine"},{"issue":"12","key":"10.1016\/j.redox.2013.06.004_bib37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1248\/bpb1978.8.1006","article-title":"Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs","volume":"8","author":"Sugiyama","year":"1985","journal-title":"Journal of Pharmacobiodynamics"},{"issue":"8","key":"10.1016\/j.redox.2013.06.004_bib38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archneurol.2010.168","article-title":"A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia","volume":"67","author":"Lynch","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.redox.2013.06.004_bib39","first-page":"22","article-title":"Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study","author":"Meier","year":"2011","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1016\/j.redox.2013.06.004_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2010.10.038","article-title":"Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA)","volume":"161","author":"Lagedrost","year":"2011","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1016\/j.redox.2013.06.004_bib41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0163-7827(03)00038-9","article-title":"Problems with essential fatty acids: time for a new paradigm?","volume":"42","author":"Cunnane","year":"2003","journal-title":"Progress in Lipid Research"},{"issue":"1","key":"10.1016\/j.redox.2013.06.004_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF01660076","article-title":"The oxidative desaturation of unsaturated fatty acids in animals","volume":"3","author":"Brenner","year":"1974","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"12","key":"10.1016\/j.redox.2013.06.004_bib43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.earlhumdev.2007.09.004","article-title":"Fatty acids and early human development","volume":"83","author":"Innis","year":"2007","journal-title":"Early Human Development"},{"issue":"6","key":"10.1016\/j.redox.2013.06.004_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1051\/rnd:2004063","article-title":"Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life","volume":"44","author":"Alessandri","year":"2004","journal-title":"Reproduction Nutrition Development"},{"issue":"4","key":"10.1016\/j.redox.2013.06.004_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nchembio727","article-title":"Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors","volume":"1","author":"Kagan","year":"2005","journal-title":"Nature Chemical Biology"},{"issue":"10","key":"10.1016\/j.redox.2013.06.004_bib46","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chemical Reviews"},{"issue":"1","key":"10.1016\/j.redox.2013.06.004_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-5793(77)81071-5","article-title":"The increase of phospholipid bilayer rigidity after lipid peroxidation","volume":"84","author":"Dobretsov","year":"1977","journal-title":"FEBS Letters"},{"issue":"5 Suppl.","key":"10.1016\/j.redox.2013.06.004_bib48","doi-asserted-by":"crossref","first-page":"715S","DOI":"10.1093\/ajcn\/57.5.715S","article-title":"Lipid peroxidation: its mechanism, measurement, and significance","volume":"57","author":"Halliwell","year":"1993","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1016\/j.redox.2013.06.004_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2010.10.690","article-title":"Isotope-reinforced polyunsaturated fatty acids protect yeast cells from oxidative stress","volume":"50","author":"Hill","year":"2011","journal-title":"Free Radical Biology and Medicine"},{"issue":"2","key":"10.1016\/j.redox.2013.06.004_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.toxlet.2011.07.020","article-title":"Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease","volume":"207","author":"Shchepinov","year":"2011","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.redox.2013.06.004_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2012.06.004","article-title":"Small amounts of isotope-reinforced polyunsaturated fatty acids suppress lipid autoxidation","author":"Hill","year":"2012","journal-title":"Free Radical Biology and Medicine"},{"issue":"4","key":"10.1016\/j.redox.2013.06.004_bib52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.freeradbiomed.2008.04.034","article-title":"A yeast PAF acetylhydrolase ortholog suppresses oxidative death","volume":"45","author":"Foulks","year":"2008","journal-title":"Free Radical Biology and Medicine"},{"issue":"4","key":"10.1016\/j.redox.2013.06.004_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.freeradbiomed.2012.06.004","article-title":"Small amounts of isotope-reinforced polyunsaturated fatty acids suppress lipid autoxidation","volume":"53","author":"Hill","year":"2012","journal-title":"Free Radical Biology and Medicine"},{"issue":"7","key":"10.1016\/j.redox.2013.06.004_bib54","doi-asserted-by":"crossref","first-page":"e6379","DOI":"10.1371\/journal.pone.0006379","article-title":"The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia","volume":"4","author":"Calmels","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.redox.2013.06.004_bib55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1087057111427949","article-title":"Primary and secondary drug screening assays for Friedreich ataxia","volume":"17","author":"Cotticelli","year":"2012","journal-title":"Journal of Biomolecular Screening"},{"issue":"8","key":"10.1016\/j.redox.2013.06.004_bib56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.25058","article-title":"A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial","volume":"27","author":"Lynch","year":"2012","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/j.redox.2013.06.004_bib57","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0891-5849(02)00848-1","article-title":"C11-BODIPY(581\/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology","volume":"33","author":"Drummen","year":"2002","journal-title":"Free Radical Biology and Medicine"},{"issue":"9","key":"10.1016\/j.redox.2013.06.004_bib58","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.freeradbiomed.2007.01.038","article-title":"Mass spectrometric analysis demonstrates that BODIPY 581\/591 C11 overestimates and inhibits oxidative lipid damage","volume":"42","author":"MacDonald","year":"2007","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"10.1016\/j.redox.2013.06.004_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/rej.2006.0506","article-title":"Reactive oxygen species, isotope effect, essential nutrients, and enhanced longevity","volume":"10","author":"Shchepinov","year":"2007","journal-title":"Rejuvenation Research"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231713000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231713000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:56:28Z","timestamp":1761976588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231713000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["S2213231713000529"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2013.06.004","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2013.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}